MedTrace Logo

Rejuvenate Modular Outcomes Study

NCT01257568 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2022-02-16

Study results available
· View outcomes & findings →

Summary

This study will be an evaluation of the Rejuvenate® Modular Hip System for primary total hip replacement (THR) with a cementless application in a consecutive series of patients who meet the eligibility criteria. Subjects will be evaluated for freedom of hip revision at 5 years and clinical outcomes for up to 10 years after surgery.

Conditions

  • Arthroplasty, Replacement, Hip

Interventions

DEVICE

Rejuvenate Modular Hip

Rejuvenate Modular Hip

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Yogesh Mittal, M.D. · The Orthopedic Center

  • Joseph Nessler, M.D. · St. Cloud Orthopaedic Associates

  • Lawrence Morawa, M.D. · Oakwood Healthcare System

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2017-06-06
Completion
2022-01-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01257568 on ClinicalTrials.gov